Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

2018 update of the EULAR recommendations for the management of Behçet's syndrome

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Placebo: den mindst skadelige behandling ved artrose?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Exercise-Induced Changes in Visceral Adipose Tissue Mass Are Regulated by IL-6 Signaling: A Randomized Controlled Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Gulen Hatemi
  • Robin Christensen
  • Dongsik Bang
  • Bahram Bodaghi
  • Aykut Ferhat Celik
  • Farida Fortune
  • Julien Gaudric
  • Ahmet Gul
  • Ina Kötter
  • Pietro Leccese
  • Alfred Mahr
  • Robert Moots
  • Yesim Ozguler
  • Jutta Richter
  • David Saadoun
  • Carlo Salvarani
  • Francesco Scuderi
  • Petros P Sfikakis
  • Aksel Siva
  • Miles Stanford
  • Ilknur Tugal-Tutkun
  • Richard West
  • Sebahattin Yurdakul
  • Ignazio Olivieri
  • Hasan Yazici
Vis graf over relationer

Several new treatment modalities with different mechanisms of action have been studied in patients with Behçet's syndrome (BS). The aim of the current effort was to update the recommendations in the light of these new data under the auspices of the European League Against Rheumatism (EULAR) Standing Committee for Clinical Affairs. A task force was formed that included BS experts from different specialties including internal medicine, rheumatology, ophthalmology, dermatology, neurology, gastroenterology, oral health medicine and vascular surgery, along with a methodologist, a health professional, two patients and two fellows in charge of the systematic literature search. Research questions were determined using a Delphi approach. EULAR standardised operating procedures was used as the framework. Results of the systematic literature review were presented to the task force during a meeting. The former recommendations were modified or new recommendations were formed after thorough discussions followed by voting. The recommendations on the medical management of mucocutaneous, joint, eye, vascular, neurological and gastrointestinal involvement of BS were modified; five overarching principles and a new recommendation about the surgical management of vascular involvement were added. These updated, evidence-based recommendations are intended to help physicians caring for patients with BS. They also attempt to highlight the shortcomings of the available clinical research with the aim of proposing an agenda for further research priorities.

TidsskriftAnnals of the Rheumatic Diseases
Udgave nummer6
Sider (fra-til)808-818
Antal sider11
StatusUdgivet - jun. 2018

ID: 54748478